BTLA (Human) Activator/Inhibitor Screening Assay, Jurkat (BTLA & NFAT-Luc)-based (CAT#: ITS-1122-LX202)

Jurkat

Human

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human BTLA (B and T lymphocyte associated, B and T lymphocyte attenuator, BTLA1, CD272, GenBank Accession #NM_181780). Which can be used in binding assays and functional assay.

Jurkat (BTLA & NFAT-Luc)

Cancer

Oncology

In Vitro Activator/Inhibitor Screening Assay

Screen for inhibitors of BTLA/HVEM interaction in cell-based co-inhibitory bioassay.

Creative Biolabs has developed several I-O function assay based on our stable cell Lines expressed the most popular immune checkpoints. BTLA (Human) Activator/Inhibitor Screening Assay, Jurkat (BTLA & NFAT-Luc)-based is applied to screen for inhibitors of BTLA/HVEM interaction in cell-based co-inhibitory bioassay. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

In Vitro Activator/Inhibitor Screening Assay; Activator/Inhibitor Screening Assay

NFAT-Luciferase Reporter

Activator/Inhibitor Screening Assay

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human BTLA (B and T lymphocyte associated, B and T lymphocyte attenuator, BTLA1, CD272, GenBank Accession #NM_181780). Which can be used in binding assays and functional assay.